Laurent Peyrin-Biroulet is an internationally-recognized expert in IBD. He is the current President of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID), a unique national network of French IBD centers running innovative clinical trials that is internationally recognised for conducting high-quality research. He is also the past President of the European and Crohn’s and Colitis Organization (ECCO) and Scientific Secretary of International Organization for the Study of IBD (IOIBD), the two leading international organizations in IBD. He is currently the principal investigator of more than 100 ongoing local, national and international academic and industry clinical trials. He is the President of the ICARE project, a European prospective cohort that has enrolled 11,000 IBD patients between 2015 and 2018 and that is assessing for the first time the real risk-benefit profile of current therapeutic strategies. He has initiated and has been responsible for numerous international projects (STRIDE initiative, defining early Crohn’s disease, use of endoscopic indexes in IBD clinical trials etc.). Thanks to his current position in international organizations (IOIBD and ECCO) he has developed several international indexes such as the WHO disability index for IBD.